Tuesday, November 10, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

NCT06162715 · PHASE2/PHASE3 · ACTIVE NOT RECRUITING · Sponsor: Vanderbilt University Medical Center · Conditions: Severe Obesity, Obesity, BMI Greater Than

PR
By Priya Raman · Science Reporter
Nov 10 07:00 ETSource: ClinicalTrials.gov

From the source

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

NCT06162715 · PHASE2/PHASE3 · ACTIVE NOT RECRUITING · Sponsor: Vanderbilt University Medical Center · Conditions: Severe Obesity, Obesity, BMI Greater Than 30.

Read at clinicaltrials.gov
PeptiPrescribed peptides from $99/moSee all →